Publication Information

{'id': 'https://openalex.org/W2470946914', 'doi': 'https://doi.org/10.1002/bdd.2020', 'title': '<i>In vivo</i> use of the CYP inhibitor 1‐aminobenzotriazole to increase long‐term exposure in mice', 'display_name': '<i>In vivo</i> use of the CYP inhibitor 1‐aminobenzotriazole to increase long‐term exposure in mice', 'publication_year': 2016, 'publication_date': '2016-07-05', 'ids': {'openalex': 'https://openalex.org/W2470946914', 'doi': 'https://doi.org/10.1002/bdd.2020', 'mag': '2470946914', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27379984'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/bdd.2020', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S57691945', 'display_name': 'Biopharmaceutics & Drug Disposition', 'issn_l': '0142-2782', 'issn': ['0142-2782', '1099-081X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5065261300', 'display_name': 'Ayahisa Watanabe', 'orcid': 'https://orcid.org/0000-0001-9759-6071'}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Ayahisa Watanabe', 'raw_affiliation_strings': ['Physicochemical &amp; Preformulation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan'], 'affiliations': [{'raw_affiliation_string': 'Physicochemical &amp; Preformulation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111244400', 'display_name': 'Kei Mayumi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Kei Mayumi', 'raw_affiliation_strings': ['Drug Metabolism &amp; Pharmacokinetics, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan'], 'affiliations': [{'raw_affiliation_string': 'Drug Metabolism &amp; Pharmacokinetics, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040252377', 'display_name': 'Kyohei Nishimura', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Kyohei Nishimura', 'raw_affiliation_strings': ['Drug Safely Evaluation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan'], 'affiliations': [{'raw_affiliation_string': 'Drug Safely Evaluation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5071568481', 'display_name': 'Hiromi Osaki', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I88302906', 'display_name': 'Futaba (Japan)', 'ror': 'https://ror.org/03b6zzt23', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I88302906']}, {'id': 'https://openalex.org/I4210118477', 'display_name': 'Shionogi (Japan)', 'ror': 'https://ror.org/01v3bqg10', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210118477']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Hiromi Osaki', 'raw_affiliation_strings': ['Physicochemical &amp; Preformulation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan'], 'affiliations': [{'raw_affiliation_string': 'Physicochemical &amp; Preformulation, Research Laboratory for Development Shionogi &amp; Co., Ltd Japan', 'institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5065261300', 'https://openalex.org/A5111244400', 'https://openalex.org/A5040252377', 'https://openalex.org/A5071568481'], 'corresponding_institution_ids': ['https://openalex.org/I88302906', 'https://openalex.org/I4210118477', 'https://openalex.org/I88302906', 'https://openalex.org/I4210118477', 'https://openalex.org/I88302906', 'https://openalex.org/I4210118477', 'https://openalex.org/I88302906', 'https://openalex.org/I4210118477'], 'apc_list': {'value': 3450, 'currency': 'USD', 'value_usd': 3450, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 3.073, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 22, 'citation_normalized_percentile': {'value': 0.797142, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '37', 'issue': '6', 'first_page': '373', 'last_page': '378'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11178', 'display_name': 'Receptor Mechanisms and Signaling', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9946, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.77953905}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.7311437}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.72579837}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.6709882}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.63811195}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.4781802}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.45026425}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.43582016}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.24631268}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.2105405}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.16647413}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.12662974}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000983', 'descriptor_name': 'Antipyrine', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D065607', 'descriptor_name': 'Cytochrome P-450 Enzyme Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000983', 'descriptor_name': 'Antipyrine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000983', 'descriptor_name': 'Antipyrine', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D000983', 'descriptor_name': 'Antipyrine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000983', 'descriptor_name': 'Antipyrine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D065607', 'descriptor_name': 'Cytochrome P-450 Enzyme Inhibitors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D065607', 'descriptor_name': 'Cytochrome P-450 Enzyme Inhibitors', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D065607', 'descriptor_name': 'Cytochrome P-450 Enzyme Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D065607', 'descriptor_name': 'Cytochrome P-450 Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008810', 'descriptor_name': 'Mice, Inbred C57BL', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009995', 'descriptor_name': 'Osmosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/bdd.2020', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S57691945', 'display_name': 'Biopharmaceutics & Drug Disposition', 'issn_l': '0142-2782', 'issn': ['0142-2782', '1099-081X'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27379984', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 22, 'referenced_works': ['https://openalex.org/W1597366779', 'https://openalex.org/W174843544', 'https://openalex.org/W1788624086', 'https://openalex.org/W1975891205', 'https://openalex.org/W1980751515', 'https://openalex.org/W1983631825', 'https://openalex.org/W2021995068', 'https://openalex.org/W2034176431', 'https://openalex.org/W2059347990', 'https://openalex.org/W2069562097', 'https://openalex.org/W2075156087', 'https://openalex.org/W2097183978', 'https://openalex.org/W2125226560', 'https://openalex.org/W2126277050', 'https://openalex.org/W2131557988', 'https://openalex.org/W2134525210', 'https://openalex.org/W2135862201', 'https://openalex.org/W2162638931', 'https://openalex.org/W2178462841', 'https://openalex.org/W2190491077', 'https://openalex.org/W2202439768', 'https://openalex.org/W63644027'], 'related_works': ['https://openalex.org/W3142128585', 'https://openalex.org/W2391021644', 'https://openalex.org/W2373403320', 'https://openalex.org/W2365953299', 'https://openalex.org/W2187393073', 'https://openalex.org/W2071398502', 'https://openalex.org/W2042241672', 'https://openalex.org/W2001333918', 'https://openalex.org/W1998860801', 'https://openalex.org/W1963842437'], 'abstract_inverted_index': {'1-Aminobenzotriazole': [0], '(ABT)': [1], 'is': [2, 24, 65, 219], 'a': [3, 21, 50, 66, 74], 'well-known': [4], 'in': [5, 77, 94, 212, 223], 'vivo': [6, 224], 'nonspecific': [7, 67], 'inhibitor': [8], 'of': [9, 18, 44, 54, 69, 82, 105, 110, 120, 139, 150, 162, 164, 182, 198, 226, 241], 'cytochrome': [10], 'P450': [11], '(CYP)': [12], 'enzymes.': [13], 'An': [14], 'effective': [15], 'dosing': [16, 52, 80], 'regimen': [17], 'ABT': [19, 55, 72, 83, 121, 142, 153, 167, 188, 199], 'for': [20, 30, 37, 56, 73, 190, 234], 'multiple-administration': [22], 'study': [23, 48], 'needed': [25], 'to': [26, 40, 62, 144, 156, 231, 238], 'conduct': [27], 'pharmacological': [28, 232], 'studies': [29, 233], 'proof-of-concept,': [31, 235], 'although': [32], 'it': [33], 'has': [34], 'been': [35], 'established': [36], 'single-administration': [38], 'study,': [39], 'characterize': [41], 'the': [42, 103, 117, 134, 137, 148, 160, 171, 208, 222, 239], 'pharmacokinetics': [43], 'drug': [45, 242, 247], 'candidates.': [46], 'This': [47], 'demonstrated': [49, 195], 'suitable': [51], 'vehicle': [53, 81, 135], 'continuous': [57, 205], 'administration': [58, 189, 206], 'and': [59, 89, 147, 179], 'increased': [60, 154], 'exposure': [61, 163, 203], 'antipyrine,': [63], 'which': [64], 'probe': [68], 'CYP,': [70], 'using': [71, 204], 'long': [75], 'period': [76], 'mice.': [78], 'The': [79, 174], 'was': [84, 168], '0.5%': [85, 90], '(w/v)': [86], 'hydroxypropyl': [87], 'methylcellulose': [88], '(v/v)': [91], 'Tween': [92], '80': [93], 'N,N-dimethylacetamide/20%': [95], 'hydroxypropyl-β-cyclodextrin': [96], 'aqueous': [97], 'solution': [98], '(2:8,': [99], 'v/v)': [100], 'based': [101], 'on': [102], 'duration': [104], 'apparent': [106], 'solubility.': [107], 'After': [108], 'implantation': [109], 'an': [111, 245], 'ALZET': [112, 209], 'osmotic': [113, 210], 'pump': [114, 211], 'with': [115, 133, 141, 152, 187, 207, 214], 'ABT,': [116], 'plasma': [118], 'concentrations': [119], 'were': [122], 'maintained': [123, 169], 'at': [124, 244], 'more': [125], 'than': [126], '4.1': [127], 'μg/ml': [128], 'over': [129, 170], '336': [130, 172], 'h.': [131, 173], 'Compared': [132], 'group,': [136], 'CLtot': [138], 'antipyrine': [140, 151, 165], 'decreased': [143], 'approximately': [145], 'one-fourth,': [146], 'BA': [149], 'up': [155], '3-fold.': [157], 'In': [158], 'addition,': [159], 'enhancement': [161], 'by': [166], 'body': [175], 'weight,': [176], 'food': [177], 'consumption': [178], 'hematological': [180], 'parameters': [181], 'mice': [183, 213], 'did': [184], 'not': [185], 'change': [186], '16': [191], 'days.': [192], 'These': [193], 'findings': [194], 'that': [196, 221], 'pretreatment': [197], 'can': [200, 228], 'increase': [201], 'long-term': [202], 'no': [215], 'overt': [216], 'toxicity.': [217], 'It': [218], 'concluded': [220], 'use': [225], '1-aminobenzotriazole': [227], 'be': [229], 'applied': [230], 'thus': [236], 'contributing': [237], 'selection': [240], 'candidates': [243], 'early': [246], 'discovery': [248], 'stage.': [249], 'Copyright': [250], '©': [251], '2016': [252], 'John': [253], 'Wiley': [254], '&': [255], 'Sons,': [256], 'Ltd.': [257]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2470946914', 'counts_by_year': [{'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 1}], 'updated_date': '2024-12-17T05:08:59.106069', 'created_date': '2016-07-22'}